ghk cu tolerance desensitization downregulation antibody formation Engineered antibodies that stabilize drug-modified KRASG12C neoantigens enable selective and potent cross-HLA immunotherapy Size:50 mg glyteine Optineuron Injection, Optineuron injection
SKU: 20769970503
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18




















